Equities research analysts at BMO Capital Markets assumed coverage on shares of Cigna Corporation (NYSE:CI) in a report released on Monday. The firm set a “market perform” rating on the health services provider’s stock.

A number of other brokerages also recently weighed in on CI. Zacks Investment Research raised Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 price objective on the stock in a research note on Monday, October 9th. Jefferies Group LLC raised their price objective on Cigna Corporation from $201.00 to $221.00 and gave the company a “buy” rating in a research note on Friday. Piper Jaffray Companies reissued a “buy” rating and issued a $191.00 price objective on shares of Cigna Corporation in a research note on Sunday, September 17th. Morgan Stanley raised their price objective on Cigna Corporation from $188.00 to $195.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Finally, BidaskClub raised Cigna Corporation from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 18th. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $192.33.

Shares of Cigna Corporation (NYSE CI) traded down 0.62% during mid-day trading on Monday, reaching $184.99. 1,218,123 shares of the company’s stock traded hands. The firm has a 50-day moving average price of $185.32 and a 200-day moving average price of $170.46. The company has a market capitalization of $46.58 billion, a P/E ratio of 21.34 and a beta of 0.43. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $193.00.

Cigna Corporation (NYSE:CI) last issued its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. During the same period last year, the business earned $1.98 EPS. The firm’s revenue was up 3.6% compared to the same quarter last year. On average, equities research analysts forecast that Cigna Corporation will post $10.03 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “BMO Capital Markets Initiates Coverage on Cigna Corporation (CI)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/16/bmo-capital-markets-initiates-coverage-on-cigna-corporation-ci.html.

In other news, insider Jason D. Sadler sold 37,756 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $176.16, for a total transaction of $6,651,096.96. Following the sale, the insider now directly owns 47,844 shares in the company, valued at $8,428,199.04. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director William D. Zollars sold 1,232 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total value of $230,667.36. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 70,653 shares of company stock worth $12,437,684. 1.30% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Cigna Corporation by 2.5% during the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock valued at $2,867,514,000 after purchasing an additional 424,469 shares during the period. BlackRock Inc. increased its position in shares of Cigna Corporation by 2,335.5% during the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after purchasing an additional 16,289,943 shares during the period. State Street Corp increased its position in shares of Cigna Corporation by 1.7% during the first quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock valued at $1,631,451,000 after purchasing an additional 190,323 shares during the period. FMR LLC increased its position in shares of Cigna Corporation by 6.7% during the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock valued at $1,156,604,000 after purchasing an additional 432,978 shares during the period. Finally, JPMorgan Chase & Co. increased its position in shares of Cigna Corporation by 40.8% during the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock valued at $684,413,000 after purchasing an additional 1,184,632 shares during the period. Institutional investors and hedge funds own 87.95% of the company’s stock.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.